Get in touch

We operate in more than 50 countries around the world. If your country is not on the list, please refer to our global contacts. 

Get in touch with our compliance hotline

Report an adverse drug reaction

Have questions?

Get in Touch.

More from Lundbeck

Investor Relations 

Detailed information related to Lundbeck’s financial performance. Contact Palle Olesen, VP Investor Relations. + 45 3083 2426 

About Us 

A global pharmaceutical company specialized in brain diseases.


For general press enquiries, please call + 45 3643 4000